SOLARA ACTIVE PHARMA SCIENCES Financial Statement Analysis
|
||
|
The Revenues of SOLARA ACTIVE PHARMA SCIENCES have decreased by -0.40% YoY .
The Earnings Per Share (EPS) of SOLARA ACTIVE PHARMA SCIENCES has decreased by Negative YoY. |
||
SOLARA ACTIVE PHARMA SCIENCES Last 5 Annual Financial Results
[BOM: 541540|NSE : SOLARA]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹1,284 Cr | ₹1,289 Cr | ₹1,444 Cr | ₹1,268 Cr | ₹1,617 Cr |
| Expenses | ₹1,077 Cr | ₹1,384 Cr | ₹1,310 Cr | ₹1,188 Cr | ₹1,231 Cr |
| Operating Profit (Excl OI) | ₹206 Cr | ₹-95 Cr | ₹134 Cr | ₹80 Cr | ₹386 Cr |
| Other Income | ₹8.32 Cr | ₹5.37 Cr | ₹23 Cr | ₹20 Cr | ₹29 Cr |
| Interest | ₹115 Cr | ₹105 Cr | ₹90 Cr | ₹75 Cr | ₹84 Cr |
| Depreciation | ₹99 Cr | ₹103 Cr | ₹111 Cr | ₹112 Cr | ₹109 Cr |
| Profit Before Tax | ₹0.54 Cr | ₹-488 Cr | ₹-45 Cr | ₹-91 Cr | ₹222 Cr |
| Profit After Tax | ₹0.54 Cr | ₹-567 Cr | ₹-22 Cr | ₹-58 Cr | ₹221 Cr |
| Consolidated Net Profit | ₹0.54 Cr | ₹-567 Cr | ₹-22 Cr | ₹-58 Cr | ₹221 Cr |
| Earnings Per Share (Rs) | ₹-1.66 | ₹0.13 | ₹-157.61 | ₹-6.16 | ₹-16.15 |
| PAT Margin (%) | -0.52 | 0.04 | -40.83 | -1.54 | -4.60 |
| ROE(%) | -0.63 | 0.05 | -46.64 | -1.47 | -3.75 |
| ROCE(%) | 4.61 | 6.07 | -17.29 | 1.79 | -0.67 |
| Total Debt/Equity(x) | 0.53 | 0.71 | 1.07 | 0.67 | 0.67 |
Key Financials |
||
| Market Cap | : | ₹ 3,103.8 Cr |
| Revenue (TTM) | : | ₹ 1,431.4 Cr |
| Net Profit(TTM) | : | ₹ -1.6 Cr |
| EPS (TTM) | : | ₹ -0.3 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SOLARA ACTIVE PHARMA SCIENCES | 4.1% | 24.4% | 4.2% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.6% | -1% | 22.2% |
| DIVIS LABORATORIES | 1.7% | 10.1% | 49.4% |
| TORRENT PHARMACEUTICALS | 1.5% | -1.2% | 38.2% |
| CIPLA | 0.7% | -3.5% | -10.4% |
| DR REDDYS LABORATORIES | -1.3% | 0.1% | -7.8% |
| MANKIND PHARMA | -1.4% | -4.6% | -4.1% |
| LUPIN | -1.9% | -9.5% | 13.2% |
| ZYDUS LIFESCIENCES | 1.4% | 4.3% | 17.7% |
SOLARA ACTIVE PHARMA SCIENCES Revenues
[BOM: 541540|NSE : SOLARA]
| Y-o-Y | -0.40 % |
| 5 Yr CAGR | -5.60 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,284 Cr | -0.40 | |
| Mar2025 | ₹1,289 Cr | -10.73 | |
| Mar2024 | ₹1,444 Cr | 13.83 | |
| Mar2023 | ₹1,268 Cr | -21.56 | |
| Mar2022 | ₹1,617 Cr | - | |
SOLARA ACTIVE PHARMA SCIENCES Operating Profit
[BOM: 541540|NSE : SOLARA]
| Y-o-Y | Positive |
| 5 Yr CAGR | -14.49 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹206 Cr | Positive | |
| Mar2025 | ₹-95 Cr | Negative | |
| Mar2024 | ₹134 Cr | 67.41 | |
| Mar2023 | ₹80 Cr | -79.28 | |
| Mar2022 | ₹386 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | -9.42 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 16.07% | Positive | |
| Mar2025 | -7.38% | Negative | |
| Mar2024 | 9.27% | 46.91 | |
| Mar2023 | 6.31% | -73.57 | |
| Mar2022 | 23.87% | - | |
SOLARA ACTIVE PHARMA SCIENCES Profit After Tax
[BOM: 541540|NSE : SOLARA]
| Y-o-Y | Positive |
| 5 Yr CAGR | -77.78 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.54 Cr | Positive | |
| Mar2025 | ₹-567 Cr | Negative | |
| Mar2024 | ₹-22 Cr | Negative | |
| Mar2023 | ₹-58 Cr | Negative | |
| Mar2022 | ₹221 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | -0.52 % | Negative | |
| Mar2025 | 0.04 % | Positive | |
| Mar2024 | -40.83 % | Negative | |
| Mar2023 | -1.54 % | Negative | |
| Mar2022 | -4.6 % | - | |
SOLARA ACTIVE PHARMA SCIENCES Earnings Per Share (EPS)
[BOM: 541540|NSE : SOLARA]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1.66 | Negative | |
| Mar2025 | ₹0.13 | Positive | |
| Mar2024 | ₹-158 | Negative | |
| Mar2023 | ₹-6.16 | Negative | |
| Mar2022 | ₹-16 | - | |
SOLARA ACTIVE PHARMA SCIENCES Return on Capital Employed (ROCE)
[BOM: 541540|NSE : SOLARA]
| Y-o-Y | -24.05 % |
| 5 Yr CAGR | Positive |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 4.61% | -24.05 | |
| Mar2025 | 6.07% | Positive | |
| Mar2024 | -17.29% | Negative | |
| Mar2023 | 1.79% | Positive | |
| Mar2022 | -0.67% | - | |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
| Current Share Price | : | ₹642.6 |
| Current MarketCap | : | ₹ 3,103.8 Cr |
| Updated EOD on | : | Sep 01,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOLARA ACTIVE PHARMA SCIENCES | 4.1% |
24.4% |
4.2% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
SOLARA ACTIVE PHARMA SCIENCES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 0.8% | 1% | 14.4% |
| BSE 1000 | -1% | -0.2% | 1.6% |
No NSE index found
You may also like the below Video Courses
FAQ about SOLARA ACTIVE PHARMA SCIENCES Financials
How the annual revenues of SOLARA ACTIVE PHARMA SCIENCES have changed ?
The Revenues of SOLARA ACTIVE PHARMA SCIENCES have decreased by -0.40% YoY .
How the Earnings per Share (EPS) of SOLARA ACTIVE PHARMA SCIENCES have changed?
The Earnings Per Share (EPS) of SOLARA ACTIVE PHARMA SCIENCES has decreased by Negative YoY .
Check out Intrinsic Value of Peers of SOLARA ACTIVE PHARMA SCIENCES
Compare Stock Analytics of Peers of SOLARA ACTIVE PHARMA SCIENCES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
